0001493152-22-035317.txt : 20221213 0001493152-22-035317.hdr.sgml : 20221213 20221213164936 ACCESSION NUMBER: 0001493152-22-035317 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221213 DATE AS OF CHANGE: 20221213 EFFECTIVENESS DATE: 20221213 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TC BioPharm (Holdings) plc CENTRAL INDEX KEY: 0001872812 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-467306 FILM NUMBER: 221460246 BUSINESS ADDRESS: STREET 1: MAXIM 1 STREET 2: 2 PARKLANDS WAY CITY: HOLYTOWN STATE: X0 ZIP: ML1 4WR BUSINESS PHONE: 01414337557 MAIL ADDRESS: STREET 1: MAXIM 1 STREET 2: 2 PARKLANDS WAY CITY: HOLYTOWN STATE: X0 ZIP: ML1 4WR FORMER COMPANY: FORMER CONFORMED NAME: TC BioPharm (Holdings) Ltd DATE OF NAME CHANGE: 20210721 FORMER COMPANY: FORMER CONFORMED NAME: TC BioPharm Ltd DATE OF NAME CHANGE: 20210714 D 1 primary_doc.xml X0708 D LIVE 0001872812 TC BioPharm (Holdings) plc MAXIM 1, 2 PARKLANDS WAY HOLYTOWN, MOTHERWELL X0 UNITED KINGDOM ML14WR +44 (0) 141 433 7557 UNITED KINGDOM None TC BioPharm (Holdings) Ltd TC BioPharm Ltd Corporation true Bryan Kobel MAXIM 1, 2 PARKLANDS WAY HOLYTOWN, MOTHERWELL X0 UNITED KINGDOM ML14WR Director Martin Thorp Maxim 1, 2 Parklands Way Holytown, Motherwell X0 UNITED KINGDOM ML14WR Executive Officer Director Michael Leek Maxim 1, 2 Parklands Way Holytown, Motherwell X0 UNITED KINGDOM ML14WR Director Mark Bonyhadi Maxim 1, 2 Parklands Way Holytown, Motherwell X0 UNITED KINGDOM ML14WR Director James Culverwell Maxim 1, 2 Parklands Way Holytown, Motherwell X0 UNITED KINGDOM ML14WR Director Arlene Morris Maxim 1, 2 Parklands Way Holytown, Motherwell X0 UNITED KINGDOM ML14WR Director Edward Niemczyk Maxim 1, 2 Parklands Way Holytown, Motherwell X0 UNITED KINGDOM ML14WR Director Biotechnology $1 - $1,000,000 06b false 2022-11-30 false true true false 0 H.C. Wainwright & Co., LLC 375 None None 430 PARK AVENUE 4TH FLOOR NEW YORK NY NEW YORK 10022 NY NEW YORK true 7350000 7350000 0 false 2 551250 0 The placement agent is also entitled to a management fee of $73,500, non-accountable expenses of $85,000 and warrants to purchase 110,250 ADSs. 0 Issuer expects to use proceeds from the offering for working capital which includes payment of salaries to executive officers. false TC BioPharm (Holdings) plc /s/ Martin Thorp Martin Thorp Chief Financial Officer 2022-12-13